As of April 5/2021... nothing Published and it is NOT known if it is SAFE or effective...Biocon's Itolizumab..a repurposed Psoriasis drug was approved with 30 patients and a deeply flawed trial study with 6 endpoints. WOW !...looks like they were setting targets After firing the gun..